Prott F J, Micke O, Haverkamp U, Pötter R, Willich N
Klinik und Poliklinik für Strahlentherapie-Radioonkologie-Westfälische Wilhelms-Universität, Münster.
Strahlenther Onkol. 1999 Jun;175 Suppl 2:76-8. doi: 10.1007/BF03038895.
Surgery is the standard treatment of soft-tissue sarcomas. Adjuvant radiotherapy with photons after less radical resection can improve local control. The rate of tumor control achieved in patients with G1 and G2 soft tissue sarcomas incompletely resected and treated postoperatively with neutron irradiation is similar to that seen in patients undergoing complete tumor resection and adjuvant photon irradiation.
At the Department of Radiotherapy and Radiation Oncology of the University of Münster, 61 patients with soft tissue sarcomas were irradiated postoperatively with fast neutrons. Mainly tumors of low or intermediate malignancy (R0; 27%; R1, 21%; R2, 52%) were treated. Malignant fibrous histiocytoma, liposarcoma, and neurogenic sarcomas dominated. 46 patients were irradiated with fast neutrons alone, and 15 patients were treated with mixed beam therapy (photons and neutrons).
The median follow-up period was 44 months. Overall five-year survival probability analysed by Kaplan-Meyer method was 42.5%. The local control rate was 57.7%. 15 patients showed complete remission, 18 patients had a partial remission. Only 11% of the patients showed grade III and IV side effects during neutron irradiation.
Neutron irradiation is efficocious in treating highly and intermediately differentiated soft tissue sarcomas. The result of surgical resection seems to be a very important prognostic factor for patients with soft tissue sarcomas.
手术是软组织肉瘤的标准治疗方法。在进行不太彻底的切除术后采用光子辅助放疗可改善局部控制。对于G1和G2级软组织肉瘤患者,在不完全切除并接受术后中子照射后所达到的肿瘤控制率,与接受肿瘤完全切除及辅助光子照射的患者相似。
在明斯特大学放射治疗与放射肿瘤学系,61例软组织肉瘤患者术后接受了快中子照射。主要治疗的是低或中度恶性肿瘤(R0;27%;R1,21%;R2,52%)。恶性纤维组织细胞瘤、脂肪肉瘤和神经源性肉瘤占主导。46例患者仅接受快中子照射,15例患者接受混合束治疗(光子和中子)。
中位随访期为44个月。采用Kaplan-Meier法分析的总体五年生存率为42.5%。局部控制率为57.7%。15例患者完全缓解,18例患者部分缓解。仅11%的患者在中子照射期间出现III级和IV级副作用。
中子照射在治疗高分化和中分化软组织肉瘤方面有效。手术切除结果似乎是软组织肉瘤患者非常重要的预后因素。